COVID-19 and obesity are two overlapping pandemics.1 Individuals with obesity are at risk of developing more severe clinical outcomes as a result of SARS-CoV-2 infection than those without obesity.2,3 Obesity is also associated with known risk factors for severe COVID-19, such as diabetes and hypertension. Irrespective of comorbidities, excessive weight results in biomechanical and systemic…
The Global Burden of Disease assessment estimates that 20% of global type 2 diabetes cases are related to chronic exposure to particulate matter (PM) with…
The study by Victoria Miller and colleagues1 in The Lancet Diabetes & Endocrinology adds to and extends the growing body of evidence of the importance…
There is debate over the nature of the carbohydrate-containing foods that should be recommended to reduce the risk of type 2 diabetes and related conditions.…
Diets with a high glycaemic index and a high glycaemic load were associated with a higher risk of incident type 2 diabetes in a multinational…
Dietary recommendations to reduce GI and GL could have effects on health outcomes that are similar to outcomes of recommendations to increase intake of fibre…
The life history theory assumes that all organisms are under selective pressure to harvest external resources and allocate them to maximise fitness: only organisms making…
Randomised controlled trials and other prospective clinical studies for novel medical interventions in people with diabetes have traditionally reported HbA1c as the measure of average…
2022 corresponds to the 100th anniversary of the discovery of glucagon. This TimeCapsule aims to recall the main steps leading to the discovery, characterisation, and…
Using prevalence data from the UK,1 we estimate that there are more than 10 000 university students with type 1 diabetes, out of a total student…
The global prevalence of diabetes—the vast majority of which is type 2 diabetes—increases steeply with age, affecting approximately one in four adults aged 75–79 years.1…
